We are live on ! Find out more
ANAB icon

AnaptysBio

127 hedge funds and large institutions have $749M invested in AnaptysBio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 42 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $673K | Put options by funds: $300K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

4% more funds holding

Funds holding: 122127 (+5)

4% more capital invested

Capital invested by funds: $720M → $749M (+$28.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.88% less ownership

Funds ownership: 101.54%100.67% (-0.88%)

29% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 42

Holders
127
Holders Change
+5
Holders Change %
+4.1%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
15
Increased
30
Reduced
42
Closed
9
Calls
$673K
Puts
$300K
Net Calls
+$373K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$204M
TCM
2
Tang Capital Management
California
$71.3M
BlackRock
3
BlackRock
New York
$50.7M +$489K +19,273 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$49.6M -$1.39M -54,911 -3%
BC
5
Boxer Capital
California
$35.3M
WP
6
Woodline Partners
California
$27.5M +$12M +473,904 +88%
State Street
7
State Street
Massachusetts
$26.2M -$8M -315,243 -25%
Federated Hermes
8
Federated Hermes
Pennsylvania
$25.6M +$987K +38,866 +4%
FM
9
Frazier Management
Washington
$24.4M
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$20.5M -$422K -16,625 -2%
GPP
11
Great Point Partners
Connecticut
$14.9M +$3.79M +149,494 +37%
RSCM
12
Rock Springs Capital Management
Maryland
$14.5M +$15.2K +600 +0.1%
PAI
13
Palo Alto Investors
California
$11.8M
BBA
14
Baker Bros. Advisors
New York
$11.6M
N
15
Nuveen
North Carolina
$11.4M +$320K +12,593 +3%
CAM
16
Cormorant Asset Management
Massachusetts
$10.4M
Geode Capital Management
17
Geode Capital Management
Massachusetts
$9.73M -$640K -25,210 -7%
Goldman Sachs
18
Goldman Sachs
New York
$9.43M +$834K +32,863 +10%
BI
19
BVF Inc
California
$9.07M -$12M -474,312 -59%
Blackstone Inc
20
Blackstone Inc
New York
$8.91M +$8.34M +328,720 New
Northern Trust
21
Northern Trust
Illinois
$7.81M -$285K -11,214 -4%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$6.88M -$123K -4,852 -2%
JP Morgan Chase
23
JP Morgan Chase
New York
$6.65M -$1.56M -61,391 -20%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$4.79M +$388K +15,270 +9%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$4.61M -$2.52M -99,100 -37%

ANAB Hedge Fund Activity: Q3 2021 in Review

127 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2021, worth a combined $749M — up 3.9% from $720M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ANAB positions and 9 closed out — a net gain of 6 holders — while 30 added to existing stakes and 42 trimmed.

The largest buyer was Woodline Partners, adding an estimated $12M. The largest seller was BVF Inc, cutting an estimated $12M.

  • 127 institutional investors held AnaptysBio (ANAB) as of Q3 2021, up from 122 in Q2 2021.
  • Funds reported $749M of AnaptysBio stock for Q3 2021, up 3.9% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest AnaptysBio buyer in Q3 2021 was Woodline Partners, an estimated $12M added.
  • The largest AnaptysBio seller in Q3 2021 was BVF Inc, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2021.